In Corio’s conversations, doctor Rafael Stellmash warns of the dangers of lung disease

Published 9/30/2021 3:04 PM / Updated 9/30/2021 3:07 PM

Brazil faces a major challenge in caring for infected patients acute lung disease. In the assessment of Dr. Rafael Stelmach, professor at the University of São Paulo’s School of Medicine and president of the ProAR Foundation, the topic has come to the fore due to the COVID-19 pandemic, but discussions about other diseases and effective treatments are still lacking. specialist He was a guest at the virtual seminar Correio Talks – The Social Impact of Serious Lung Diseases, broadcast through the newspaper’s social networks (website, Facebook, Instagram and YouTube).

Stelmach stated that the file Lung disease is not well known by the populationThis was even more evident with the case of Covid. You said last year that people finally realized that we have lungs, not just hearts. He said people died of respiratory disease, but the report was due to heart disease.” “That’s changing. He noted that chronic diseases, especially the most serious, actually start out as neither very severe nor serious.

the teacher He has a consolidated career in health and also an important job related to management.. The doctor defends the importance of the Parliamentary Front for Immunization and the involvement of society in this matter. “The doctor receives and helps patients, but interaction with Brazil is not common. This made me interested in the issue of implementation. I had the opportunity to implement the first protocol for chronic lung diseases here in São Paulo,” he confirmed at the session.

ProAR

The ProAR Foundation brings together health professionals, patients, and enthusiasts who aim to expand access to diagnosis and Treatment of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease, lung cancer, cystic fibrosis and tuberculosis. Leading this project, Raphael Stelmach explained mediating the relationship between professionals, industries, organizations and civil society. “It is a private organization, but it is based on public and private procedures. The goal is implementation. Applying the technologies and needs of patients and working together,” he said.

“It is not only for educators and health professionals, but also for people, patients or not, who want to participate with us in this task. Therefore, our approach is towards the Parliamentary Front as well as the Patients Association,” the doctor said.

The World Health Organization (WHO) defines respiratory diseases as those that chronically affect the upper and lower airways. These disorders are associated with genetic and genetic factors, such as cystic fibrosis and pulmonary arterial hypertension, for example, while others are preventable.

“